Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
The Test for the Evaluation of Emotions and Socialisation (TEEMS) is a new psychological assessment tool that evaluates social cognitive skills in children and young people. The TEEMS tool addresses a substantial unmet need, leading the field internationally as the first comprehensive social
A Melbourne-led study has uncovered a new neurodegenerative disorder in which children experience developmental regression and severe epilepsy. The study, led by the Murdoch Children's Research Institute and published in The American Journal of Human Genetics, found a variation in a gene causes a
More than half of people with mitochondrial disease can be diagnosed via genomic sequencing, according to a new study.
Hello Andrea, it's lovely to speak with you. As the Director of People and Culture at Murdoch Children's Research Institute (MCRI), what excites you most about this role?
So far in 2024 there have been more than 17,000 cases of whooping cough (pertussis) across Australia. This is well above our usual national average. It’s already six times more cases than we saw in all of 2023. News headlines in multiple states have warned of whooping cough outbreaks over recent
The Murdoch Children’s Research Institute has welcomed a $35 million election pledge by the Andrews Labor Government to fund Stage 2 of the Victorian Paediatric Cancer Consortium (VPCC) that aims to improve childhood cancer survival rates. The funding, the biggest investment of its kind in
LongSTEPPP stands for the Longitudinal Study of Teenagers with Endometriosis, Period and Pelvic Pain in Australia and is a 5-year study starting in 2022.
Emma was just seven weeks old when she started shaking in her mother Jenny’s arms. Instead of taking Emma to her eight-week routine immunisation appointment, Jenny was at her local clinic asking for a referral to see a paediatrician. But due to long waiting lists, it would be months before Emma
This study is complete. This clinical drug trial aims to determine whether oral olanzapine is more effective than oral diazepam for the management of acute severe behavioural disturbance (ASBD) in children and adolescents presenting to Emergency Departments (EDs).
Page 71 of 103
